Month: May 2018

Newmont Mining Corporation NEM has entered into a deal to sell its royalty portfolio to an emerging precious metals royalty and streaming company, Maverix Metals Inc. The strategic partnership will provide Newmont an ongoing exposure to Maverix’s growing portfolio of 27 high-quality royalties and streams, out of which 10 are on producing mines. […]

Independent Bank Corp. INDB has entered into an agreement with MNB Bancorp to acquire the latter. While the agreement has been approved by the board of directors of the companies, the closing of the transaction (anticipated in the fourth quarter of 2018) is subject to certain regulatory approvals. […]

On May 30, we issued an updated research report on Actuant Corporation ATU . This premium diversified industrial behemoth provides highly engineered motion control solutions, premium hydraulic solutions and tools in more than 30 countries. […]

Micron Technologies, Inc. MU shares rallied to close at $62.62 on May 29, reaching an 18-year high. […]

WellCare Health Plans, Inc. WCG is set to acquire Meridian Health Plans of Michigan and Illinois and MeridianRx, a pharmacy benefit manager (PBM) to become the top-most Medicaid provider in the aforementioned states. The company would be paying a total of $2.5 billion in cash. […]

After some uneventful weeks, political and geopolitical tensions escalated, triggering a broad sell-off in the global stock markets. The latest news from Italy, Spain, and White House wreaked havoc leading to the risk-off sentiments. Politics Weigh The prospect of new elections in Italy has raised fears of de facto referendum on the country’s membership in the euro while Spain might also head toward a snap election, given that prime minister Mariano Rajoy will face a vote of confidence on his leadership on Jun 1 […]

Intercontinental Exchange Inc . ICE has agreed to acquire TMC Bonds LLC for $685 million in cash. […]

Drug Approvals and licensing deals were the areas of focus in the biotech space last week. While Gilead’s HCV Drug, Eplcusa, was approved in China, BioMarin’s Palynziq got FDA approval. On the other hand, Alexion’s offer to acquire Sweden-based Wilson Therapeutcis was accepted by the latter’s shareholders […]

Novo Nordisk NVO announced headline results from PIONEER 2, the second phase IIIa study with oral formulation of Ozempic (semaglutide) for treatment of adults with type II diabetes. The study evaluated the efficacy and safety of 14 mg oral Ozempic compared with 25 mg Eli Lilly LLY and Boehringer Ingelheim’s Jardiance (empagliflozin) with type II diabetes inadequately controlled on metformin. The 52 week study achieved its primary objective and demonstrated a statistically significant and superior improvement in blood glucose levels (HbA1c) with oral Ozempic compared to Jardiance at 26 weeks […]

The recent political development in Italy has unexpectedly raised concerns across investors communities throughout the globe. Italy, Eurozone's third-largest economy, is witnessing a political turmoil involving a power struggle between the Eurosceptic populists and the pro-European Union (EU) establishment politicians. Italy’s President Sergio Mattarella has rejected the appointment of populists’ Paolo Savona as the economy minister after he advocated Italy to exit from the euro but not EU. […]